You are here: All Products  > InxMed of Shanghai Doses First Patient in US Trial of FAK Inhibitor

InxMed of Shanghai Doses First Patient in US Trial of FAK Inhibitor

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products